Thailand’s Advanced Therapy Medicinal Products (ATMP) and cell banking sector is witnessing a key...
MEDEZE Targets THB1 Billion Revenue in 2026 on ATMPs and Stem Cell Innovations
Dr. Veerapol Khemarangsan, Managing Director of Medeze Group Public Company Limited (SET: MEDEZE), revealed...
MEDEZE Navigates Economic Headwinds in 3Q25 with Strategic Advancement in ATMPs
MEDEZE Group Public Company Limited (SET: MEDEZE) reported a decline in profitability for the...


